Cosmo licenses Aemcolo™ for the USA to RedHill Biopharma and takes a 19.56% stake in the company
Cosmo Pharmaceuticals N.V. today announced that it has concluded a licensing agreement for Aemcolo™ for the USA and a simultaneous share subscription agreement with RedHill Biopharma (NASDAQ: RDHL, Tel-Aviv Stock Exchange: RDHL).